Neuberger Berman Group
PRCT icon

Neuberger Berman Group’s Procept Biorobotics PRCT Stock Holding History

Neuberger Berman Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,180
Closed -$298K – 2128
2025
Q2 		$298K Sell
5,180
-1,983
-28% -$112K ﹤0.01% 1731
2025
Q1 		$417K Sell
7,163
-2,799
-28% -$191K ﹤0.01% 1582
2024
Q4 		$802K Buy
9,962
+4,988
+100% +$426K ﹤0.01% 1378
2024
Q3 		$399K Buy
+4,974
New +$353K ﹤0.01% 1583

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group's PRCT Position: Q3 2025 in Review

Neuberger Berman Group sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 5,180 shares — an estimated $298K sold.

Neuberger Berman Group first reported a position in PRCT in Q3 2024 and held it in 4 quarters. The position peaked at $802K in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Neuberger Berman Group reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 5,180 Procept Biorobotics shares in Q3 2025, an estimated $298K.
  • Neuberger Berman Group first reported a position in Procept Biorobotics in Q3 2024 and held it in 4 quarters.
  • Neuberger Berman Group's Procept Biorobotics position peaked at $802K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.